Company intelligence / Profile preview

HL Genomics

Yongin-si, Gyeonggi, Republic of Koreahlgenomics.com ↗
Ownership
Private
Development stage
Other
01

Overview

HL Genomics manufactures and supplies a range of active pharmaceutical ingredients—including small molecules like bepotastine—and biologics such as insulin and vaccines. The company holds multiple regulatory registrations for its products in major markets including the US, EU, Japan, Korea. No clinical trial results are reported as it operates primarily as an ingredient/API supplier.

Pipeline Breadth & Programs HL Genomics does not appear to have a traditional R&D pipeline but rather offers a portfolio of commercialized APIs:

| name | stage | modality | target | indication | |--------------|------------|--------------|------------------|---------------------------| | bepotastine | Commercial | Small molecule | Histamine receptor* | Allergic conjunctivitis/rhinitis* | *(Other programs include various antibiotics [erythromycin], hormones [insulin], antimalarials etc.; all at commercial stage)*

(Asterisk denotes inference based on standard use/product class.)

Therapeutic areas
OncologyEndocrinologyImmunologyInfectious Diseases
Modalities
Small moleculeBiologicProteinVaccineHormoneAntibioticSteroid
Industry
Contract Manufacturing Organization

Beyond the preview

Go deeper on HL Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HL Genomics.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call